EMMA
Emmaus Life Sciences, Inc.
$0.01
+0.00 (+0.00%)
At close · Jul 7
Going-concern doubt
— flagged May 15, 2026
Substantial doubt about the company's ability to continue as a going concern.
“Due to the uncertainty of the Company’s ability to meet its current liabilities and operating expenses, there is substantial doubt about the Company’s ability to continue as a going concern for 12 months from the date that these condensed consolidated financial statements are issued.”View the 10-Q filed May 15, 2026
Market Cap
$801,550
Shares
70,188,263
Income-statement, balance-sheet and cash-flow figures extracted from the company's SEC filings — 10-K annual and 10-Q quarterly reports — and standardised for comparison across periods.
Revenue
$12.45M
-25.2%
FY2025
Net Income
-$7.49M
-16.1%
FY2025
Gross Margin
93.12%
+0.3pp
FY2025
Operating Margin
1.85%
+13.2pp
FY2025
Diluted EPS
-$0.12
-20%
FY2025
Operating Cash Flow
-$11K
+99.5%
FY2025
Chart any reported metric, KPI or segment over time — the full statement history lives here
Search above to add metrics — fundamentals, product and segment revenue, company KPIs, valuation.
| Line Item | TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 | FY2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| $12.03M | $12.45M | $16.65M | $29.6M | $18.39M | $20.61M | $23.17M | $22.75M | $16.46M | — | — | — | — | — | — | — | |
| $800K | $857K | $1.2M | $1.34M | $2.59M | $3.31M | $2.25M | $1.09M | $993K | $53.5K | $5500 | $4900 | — | — | — | — | |
| $11.23M | $11.6M | $15.45M | $28.26M | $15.8M | $17.3M | $20.92M | $21.66M | $15.47M | — | — | — | — | — | — | — | |
| — | 93.12% | 92.79% | 95.47% | 85.93% | 83.93% | 90.3% | 95.19% | 93.97% | — | — | — | — | — | — | — | |
| $177K | $313K | $657K | $1.19M | $1.73M | $4.11M | $2.41M | $2.18M | $1.72M | — | — | — | — | — | — | — | |
| $2.97M | $2.87M | $6M | $8.64M | $7.49M | $5.88M | $4.87M | $6.98M | $4.73M | $1.23M | $522K | $347.9K | $390.2K | $347.5K | $997.1K | $1.23M | |
| $7.69M | $8.18M | $10.69M | $14.89M | $13.17M | $13.44M | $13.68M | $17.01M | $17.46M | $4.59M | $2.53M | $1.62M | $2.03M | $2.55M | $2.94M | $4.27M | |
| — | $39K | $22K | $32K | $53K | $59K | $60K | $73K | $61K | $48.7K | $7200 | $7600 | — | — | — | — | |
| $10.84M | $11.37M | $17.35M | $24.72M | $22.39M | $23.43M | $20.95M | $26.17M | $23.92M | $7.23M | $3.85M | $2.76M | $3.95M | $4.33M | $4.92M | $6.58M | |
| $388K | $231K | -$1.89M | $3.54M | -$6.59M | -$6.13M | -$32K | -$4.51M | -$8.45M | -$7.1M | -$3.77M | -$2.66M | -$3.82M | -$4.2M | -$4.81M | -$5.83M | |
| — | 1.85% | -11.37% | 11.96% | -35.81% | -29.73% | -0.14% | -19.83% | -51.36% | — | — | — | — | — | — | — | |
| — | $270K | -$1.87M | $3.57M | -$6.53M | -$6.07M | $28K | -$4.44M | -$8.39M | -$7.05M | -$3.76M | -$2.65M | — | — | — | — | |
| $8M | $7.13M | $5.49M | $7.38M | $5.01M | $3.1M | $5.99M | $27.63M | $22.8M | — | — | — | — | — | — | — | |
| -$41M | — | — | — | — | — | — | — | -$86.3K | -$6600 | -$2.17M | -$724.6K | $1.16M | -$6.69M | $1.89M | -$3.04M | |
| -$366K | — | — | -$1.71M | -$1.91M | -$2.73M | -$2.06M | -$414K | -$97K | — | — | — | — | — | — | — | |
| -$8.49M | -$7.48M | -$6.42M | -$3.79M | -$10.57M | -$15.92M | $973K | -$54.68M | -$72.55M | -$7.11M | -$5.94M | -$3.38M | -$2.65M | -$10.89M | -$2.91M | -$8.87M | |
| $9000 | $9000 | $29K | -$59K | $60K | $25K | -$381K | $164K | $39K | $2600 | $2000 | $5000 | $5200 | $800 | $1900 | $1300 | |
| -$8.5M | -$7.49M | -$6.45M | -$3.73M | -$10.63M | -$15.95M | $1.35M | -$54.84M | -$72.59M | -$7.11M | -$5.94M | -$3.38M | -$2.66M | -$10.91M | -$3.41M | -$8.87M | |
| — | -60.16% | -38.75% | -12.61% | -57.78% | -77.37% | 5.84% | -241.04% | -441.02% | — | — | — | — | — | — | — | |
| $144K | — | — | — | — | — | — | — | $734.4K | — | — | — | — | — | — | — | |
| — | — | — | — | — | — | — | — | -$9.65M | -$7.11M | -$5.94M | -$3.38M | — | -$10.91M | -$3.41M | — | |
| -$9.35M | -$7.23M | -$9.29M | -$1.27M | -$12.99M | -$17.35M | $2.58M | -$54.85M | -$72.57M | — | — | — | — | — | — | — | |
| USD/shares | — | -$0.12 | -$0.10 | -$0.07 | -$0.21 | -$0.32 | — | — | — | — | — | — | — | -$0.14 | -$1.81 | -$0.16 |
| USD/shares | — | -$0.12 | -$0.10 | -$0.07 | -$0.21 | -$0.32 | — | — | — | — | — | — | — | -$0.14 | -$1.81 | -$0.16 |
| shares | — | 64.04M | 63.23M | 53.11M | 49.44M | 49.25M | 48.9M | 42.26M | 36.86M | 2.82M | 641.84K | 101.81M | 99.33M | 75.8M | 1.89M | 56.07M |
| shares | — | 64.04M | 63.23M | 53.11M | 49.44M | 49.25M | — | — | 5.2M | 2.82M | 641.84K | 101.81M | 99.33M | 75.8M | 1.89M | 56.07M |
Italic rows are computed from reported lines — open a row's info icon for its formula. Values reflect the latest filing (restatements included); per-share figures on today's split basis. Click a value for its source filing.
TTM: trailing twelve months through the latest reported quarter — flows sum the last four quarters, balances take the latest. 3Y/5Y/10Y columns are trailing CAGR from the newest fiscal year; blank where an endpoint is missing or negative.
Revenue Breakdown
Annual revenue as the company disaggregates it in its own XBRL filings. Years a component wasn't reported show a dash.
Share mode is each component's slice of the reported components that year — issuers rarely tag every revenue dollar, so slices need not sum to total revenue.
By Product & Service (USD)
| Component | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 |
|---|---|---|---|---|---|---|---|
| Endari US | $9,048,000 | $13,478,000 | $21,998,000 | — | — | — | — |
| Endari International | $3,180,000 | $2,669,000 | $6,963,000 | — | — | — | — |
| Product And Service Other | $225,000 | $506,000 | $636,000 | $536,000 | $493,000 | $603,000 | $441,000 |
| Endari | — | — | — | $17,854,000 | $20,117,000 | $22,564,000 | $22,311,000 |